Alpha-2-HS-glycoprotein
| GO Term | Evidence Code | Reference |
|---|---|---|
| skeletal system development | ||
| ossification |
|
|
| pinocytosis | ||
| acute-phase response | ||
| acute-phase response |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region |
| GO Term | Evidence Code | Reference |
|---|---|---|
| endopeptidase inhibitor activity | ||
| cysteine-type endopeptidase inhibitor activity | ||
| kinase inhibitor activity |
| Pathway Name | Organism |
|---|---|
| Neutrophil degranulation | Homo sapiens |
| Platelet degranulation | Homo sapiens |
| Post-translational protein phosphorylation | Homo sapiens |
| Regulation of IGF Activity by IGFBP | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9352 | type 2 diabetes mellitus | |
| DOID:0080628 | alopecia-mental retardation syndrome 1 | |
| DOID:3393 | coronary artery disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026